Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

dc.contributor.authorPowell, Matthew A.
dc.contributor.authorHietanen, Sakari
dc.contributor.authorColeman, Robert L.
dc.contributor.authorMonk, Bradley J.
dc.contributor.authorZub, Oleksandr
dc.contributor.authorO'Malley, David M.
dc.contributor.authorGilbert, Lucy
dc.contributor.authorPodzielinski, Iwona
dc.contributor.authorAngioli, Roberto
dc.date.accessioned2023-11-26T11:32:04Z
dc.date.available2023-11-26T11:32:04Z
dc.date.issued2023
dc.description.abstractПацієнти (пацієнти) з первинною прогресуючою стадією III або IV або першим рецидивним раком ендометрыю були рандомізовані 1:1 для отримання достарлімабу 500 мг або PBO плюс карбоплатину AUC 5 і паклітакселу 175 мг/м2 Q3W (6 циклів), потім достарлімабу 1000 мг , або PBO, монотерапія Q6W до 3 років.en_US
dc.identifier.citationDostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) / M. A. Powell, S.Hietanen, R. L. Coleman, B. J. Monk, O. Zub [et al.] // Journal of Clinical Oncology. – 2023. – № 16. – P. 5503.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/33057
dc.language.isoen_USen_US
dc.subjectstandard of careen_US
dc.subjectanti–programmed deathen_US
dc.subjectcarboplatin paclitaxelen_US
dc.subject2023аen_US
dc.titleDostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
powell-et-al-2023-dostarlimab-for-primary-advanced-or-recurrent-(a-r)-endometrial-cancer-(ec)-outcomes-by-blinded.pdf
Size:
38.61 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description: